SuspendedNCT01921998

Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Christie NHS Foundation Trust
Principal Investigator
Alastair Greystoke
The Christie NHS Foundation Trust
Intervention
Biomarker and health economics(procedure)
Enrollment
50 target
Eligibility
18 years · All sexes
Timeline
2013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01921998 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma →

← Back to all trials